|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.016764
|
|
|
VRNI
|
[NCBI]
|
0.00483768
|
|
|
IS1
|
[NCBI]
|
0.00374499
|
|
|
RA
|
[NCBI]
|
0.00348351
|
|
|
KLK3
|
[NCBI]
|
0.00282119
|
|
|
SLE
|
[NCBI]
|
0.00118768
|
|
|
vitreoretinal degeneration, snowflake type
|
[NCBI]
|
0.000982519
|
|
|
CEACAM5
|
[NCBI]
|
0.000957365
|
|
|
temporal arteritis
|
[NCBI]
|
0.00063856
|
|
|
PTH
|
[NCBI]
|
0.000619911
|
|
|
CRC
|
[NCBI]
|
0.000558864
|
|
|
MDD
|
[NCBI]
|
0.000552594
|
|
|
SHBG
|
[NCBI]
|
0.000524673
|
|
|
CD
|
[NCBI]
|
0.000356943
|
|
|
OD
|
[NCBI]
|
0.000338095
|
|
|
EPO
|
[NCBI]
|
0.000324361
|
|
|
pelvic organ prolapse
|
[NCBI]
|
0.000316935
|
|
|
cataract, age-related cortical
|
[NCBI]
|
0.000316935
|
|
|
testicular microlithiasis
|
[NCBI]
|
0.000316935
|
|
|
AFP
|
[NCBI]
|
0.000297173
|
|
|
TNF
|
[NCBI]
|
0.000271189
|
|
|
CF
|
[NCBI]
|
0.000263597
|
|
|
nipples, supernumerary
|
[NCBI]
|
0.000257752
|
|
|
otitis media, susceptibility to
|
[NCBI]
|
0.000257752
|
|
|
PD
|
[NCBI]
|
0.000250485
|
|
|
EGF
|
[NCBI]
|
0.000244983
|
|
|
FA
|
[NCBI]
|
0.000237713
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.000233637
|
|
|
behcet syndrome
|
[NCBI]
|
0.000229656
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.000217552
|
|
|
FECD2
|
[NCBI]
|
0.000215237
|
|
|
cerebral palsy, ataxic, autosomal recessive
|
[NCBI]
|
0.000215237
|
|
|
lethal congenital contracture syndrome 1
|
[NCBI]
|
0.000215237
|
|
|
NGFB
|
[NCBI]
|
0.000209468
|
|
|
VUR1
|
[NCBI]
|
0.000202655
|
|
|
chiari malformation type i
|
[NCBI]
|
0.000202655
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000189264
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.00018254
|
|
|
MVP
|
[NCBI]
|
0.000175951
|
|
|
MBL2
|
[NCBI]
|
0.000163001
|
|
|
RNASE3
|
[NCBI]
|
0.000161977
|
|
|
IH
|
[NCBI]
|
0.000156332
|
|
|
NYS2
|
[NCBI]
|
0.000156332
|
|
|
PWS
|
[NCBI]
|
0.000147407
|
|
|
APOE
|
[NCBI]
|
0.000143594
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000140483
|
|
|
TG
|
[NCBI]
|
0.00012828
|
|
|
TH
|
[NCBI]
|
0.000126312
|
|
|
histidinemia
|
[NCBI]
|
0.000124628
|
|
|
ARMD1
|
[NCBI]
|
0.000120944
|
|
|
MAFD6
|
[NCBI]
|
0.000118715
|
|
|
AMH
|
[NCBI]
|
0.000115357
|
|
|
BWS
|
[NCBI]
|
0.000114219
|
|
|
MAFD1
|
[NCBI]
|
0.000111579
|
|
|
palatopharyngeal incompetence
|
[NCBI]
|
0.000106518
|
|
|
CMM
|
[NCBI]
|
0.000103733
|
|
|
centralopathic epilepsy
|
[NCBI]
|
0.000101114
|
|
|
melanoma, uveal
|
[NCBI]
|
0.00010018
|
|
|
CRP
|
[NCBI]
|
9.91284e-05
|
|
|
ALB
|
[NCBI]
|
9.34237e-05
|
|
|
VEGF
|
[NCBI]
|
9.18725e-05
|
|
|
AT
|
[NCBI]
|
9.12131e-05
|
|
|
GBD1
|
[NCBI]
|
8.92403e-05
|
|
|
sjogren syndrome
|
[NCBI]
|
8.77797e-05
|
|
|
KTCN1
|
[NCBI]
|
8.59983e-05
|
|
|
LBP
|
[NCBI]
|
8.5167e-05
|
|
|
MFS
|
[NCBI]
|
8.5113e-05
|
|
|
ACHE
|
[NCBI]
|
8.45766e-05
|
|
|
PAEP
|
[NCBI]
|
7.99567e-05
|
|
|
TFPI
|
[NCBI]
|
7.58746e-05
|
|
|
IFNA1
|
[NCBI]
|
7.37969e-05
|
|
|
breath-holding spells
|
[NCBI]
|
7.25762e-05
|
|
|
VIP
|
[NCBI]
|
7.04331e-05
|
|
|
GFAP
|
[NCBI]
|
6.6429e-05
|
|
|
TSD
|
[NCBI]
|
6.51996e-05
|
|
|
NPY
|
[NCBI]
|
6.48683e-05
|
|
|
RTT
|
[NCBI]
|
6.20558e-05
|
|
|
AD
|
[NCBI]
|
6.13376e-05
|
|
|
PGR
|
[NCBI]
|
6.05142e-05
|
|
|
BDNF
|
[NCBI]
|
5.95425e-05
|
|
|
MBP
|
[NCBI]
|
5.92175e-05
|
|
|
MJD
|
[NCBI]
|
5.77184e-05
|
|
|
BFH
|
[NCBI]
|
5.73896e-05
|
|
|
MYP2
|
[NCBI]
|
5.71644e-05
|
|
|
PCOS1
|
[NCBI]
|
5.68938e-05
|
|
|
ADA
|
[NCBI]
|
5.65114e-05
|
|
|
ALD
|
[NCBI]
|
5.43846e-05
|
|
|
CPB2
|
[NCBI]
|
5.13423e-05
|
|
|
PF4
|
[NCBI]
|
5.12707e-05
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
4.93201e-05
|
|
|
BGLAP
|
[NCBI]
|
4.83939e-05
|
|
|
AIS
|
[NCBI]
|
4.55417e-05
|
|
|
ASD2
|
[NCBI]
|
4.18945e-05
|
|
|
cataract, lamellar 2
|
[NCBI]
|
4.18945e-05
|
|
|
PXE
|
[NCBI]
|
4.09282e-05
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
3.98734e-05
|
|
|
osteoporosis
|
[NCBI]
|
3.95488e-05
|
|
|
CSF3
|
[NCBI]
|
3.83657e-05
|
|
|
EIG
|
[NCBI]
|
3.73969e-05
|
|
|
GPS
|
[NCBI]
|
3.62592e-05
|
|
|
cayler cardiofacial syndrome
|
[NCBI]
|
3.62592e-05
|
|
|
angioid streaks
|
[NCBI]
|
3.20609e-05
|
|
|
retinitis pigmentosa, late-adult onset
|
[NCBI]
|
3.20609e-05
|
|
|
phace association
|
[NCBI]
|
3.20609e-05
|
|
|
ARVD11
|
[NCBI]
|
3.20609e-05
|
|
|
dermatitis herpetiformis, familial
|
[NCBI]
|
3.20609e-05
|
|
|
cataract, age-related nuclear
|
[NCBI]
|
3.20609e-05
|
|
|
cushing disease, pituitary
|
[NCBI]
|
3.20609e-05
|
|
|
hepatitis b vaccine, response to
|
[NCBI]
|
3.20609e-05
|
|
|
DMD
|
[NCBI]
|
3.19046e-05
|
|
|
CXADR
|
[NCBI]
|
3.12406e-05
|
|
|
REG3A
|
[NCBI]
|
3.0989e-05
|
|
|
CNTF
|
[NCBI]
|
3.09001e-05
|
|
|
ATHS
|
[NCBI]
|
3.08339e-05
|
|
|
KRT20
|
[NCBI]
|
3.07818e-05
|
|
|
ADIPOQ
|
[NCBI]
|
2.97886e-05
|
|
|
CTHM
|
[NCBI]
|
2.84804e-05
|
|
|
AVSD
|
[NCBI]
|
2.81894e-05
|
|
|
DHFR
|
[NCBI]
|
2.75684e-05
|
|
|
OCP
|
[NCBI]
|
2.6722e-05
|
|
|
ESR1
|
[NCBI]
|
2.66272e-05
|
|
|
DFSP
|
[NCBI]
|
2.65377e-05
|
|
|
CVID
|
[NCBI]
|
2.64157e-05
|
|
|
EV
|
[NCBI]
|
2.62211e-05
|
|
|
MS
|
[NCBI]
|
2.62211e-05
|
|
|
CFH
|
[NCBI]
|
2.61581e-05
|
|
|
resting heart rate
|
[NCBI]
|
2.59027e-05
|
|
|
isotretinoin embryopathy-like syndrome
|
[NCBI]
|
2.59027e-05
|
|
|
CORD6
|
[NCBI]
|
2.59027e-05
|
|
|
hydroxyprolinemia
|
[NCBI]
|
2.59027e-05
|
|
|
ACPP
|
[NCBI]
|
2.57299e-05
|
|
|
PCNA
|
[NCBI]
|
2.45085e-05
|
|
|
GAPDH
|
[NCBI]
|
2.43191e-05
|
|
|
EVA
|
[NCBI]
|
2.39156e-05
|
|
|
GNRH1
|
[NCBI]
|
2.38269e-05
|
|
|
VDR
|
[NCBI]
|
2.37453e-05
|
|
|
FRDA
|
[NCBI]
|
2.34367e-05
|
|
|
CMH
|
[NCBI]
|
2.29789e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
2.28946e-05
|
|
|
TF
|
[NCBI]
|
2.23793e-05
|
|
|
MCDR1
|
[NCBI]
|
2.17985e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
2.16554e-05
|
|
|
CFTR
|
[NCBI]
|
2.15458e-05
|
|
|
recombinant chromosome 8 syndrome
|
[NCBI]
|
2.149e-05
|
|
|
melanoma-pancreatic cancer syndrome
|
[NCBI]
|
2.149e-05
|
|
|
intracranial hypertension, idiopathic
|
[NCBI]
|
2.149e-05
|
|
|
TNFSF6
|
[NCBI]
|
2.14861e-05
|
|
|
ADHD
|
[NCBI]
|
2.10781e-05
|
|
|
brugada syndrome 1
|
[NCBI]
|
2.09943e-05
|
|
|
PON1
|
[NCBI]
|
2.08595e-05
|
|
|
OPMD
|
[NCBI]
|
2.07188e-05
|
|
|
RP
|
[NCBI]
|
2.01872e-05
|
|
|
APC
|
[NCBI]
|
2.01492e-05
|
|
|
PG
|
[NCBI]
|
2.01347e-05
|
|
|
ANG
|
[NCBI]
|
1.99563e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
1.94752e-05
|
|
|
AR
|
[NCBI]
|
1.93021e-05
|
|
|
GTS
|
[NCBI]
|
1.89745e-05
|
|
|
SCA1
|
[NCBI]
|
1.89479e-05
|
|
|
COMP
|
[NCBI]
|
1.82855e-05
|
|
|
corneal dystrophy, epithelial basement membrane
|
[NCBI]
|
1.81055e-05
|
|
|
FOLH1
|
[NCBI]
|
1.80822e-05
|
|
|
FFI
|
[NCBI]
|
1.80758e-05
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
1.80662e-05
|
|
|
CCK
|
[NCBI]
|
1.78459e-05
|
|
|
FSHMD1A
|
[NCBI]
|
1.7286e-05
|
|
|
factor v deficiency
|
[NCBI]
|
1.69766e-05
|
|
|
CNC1
|
[NCBI]
|
1.67603e-05
|
|
|
MTHFR
|
[NCBI]
|
1.67537e-05
|
|
|
TYMS
|
[NCBI]
|
1.6695e-05
|
|
|
FGF23
|
[NCBI]
|
1.58189e-05
|
|
|
sudden infant death syndrome
|
[NCBI]
|
1.55444e-05
|
|
|
cerebral palsy, spastic, symmetric, autosomal recessive
|
[NCBI]
|
1.54003e-05
|
|
|
pancreatic cancer, susceptibility to, 1
|
[NCBI]
|
1.54003e-05
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
1.54003e-05
|
|
|
sturge-weber syndrome
|
[NCBI]
|
1.54003e-05
|
|
|
CJD
|
[NCBI]
|
1.51311e-05
|
|
|
SELP
|
[NCBI]
|
1.46499e-05
|
|
|
MEN1
|
[NCBI]
|
1.45124e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
1.45099e-05
|
|
|
CRMO
|
[NCBI]
|
1.44114e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
1.44114e-05
|
|
|
HPS
|
[NCBI]
|
1.4197e-05
|
|
|
HSCR1
|
[NCBI]
|
1.38585e-05
|
|
|
SPP1
|
[NCBI]
|
1.38276e-05
|
|
|
ZNF202
|
[NCBI]
|
1.36632e-05
|
|
|
LGALS13
|
[NCBI]
|
1.36632e-05
|
|
|
aortic valve disease
|
[NCBI]
|
1.35266e-05
|
|
|
GH1
|
[NCBI]
|
1.32618e-05
|
|
|
CRH
|
[NCBI]
|
1.32557e-05
|
|
|
creatine deficiency syndrome, x-linked
|
[NCBI]
|
1.31779e-05
|
|
|
antiphospholipid syndrome
|
[NCBI]
|
1.31779e-05
|
|
|
hyperbilirubinemia, transient familial neonatal
|
[NCBI]
|
1.31779e-05
|
|
|
wilson disease
|
[NCBI]
|
1.30562e-05
|
|
|
SOD2
|
[NCBI]
|
1.24839e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
1.22598e-05
|
|
|
LS
|
[NCBI]
|
1.22598e-05
|
|
|
SLC34A2
|
[NCBI]
|
1.22256e-05
|
|
|
GAL
|
[NCBI]
|
1.21197e-05
|
|
|
FABP2
|
[NCBI]
|
1.18201e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
1.15832e-05
|
|
|
SLOS
|
[NCBI]
|
1.13588e-05
|
|
|
aspirin resistance
|
[NCBI]
|
1.13166e-05
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
1.13166e-05
|
|
|
KIR2DL3
|
[NCBI]
|
1.10933e-05
|
|
|
KIR2DL2
|
[NCBI]
|
1.10933e-05
|
|
|
PJS
|
[NCBI]
|
1.10817e-05
|
|
|
IL18
|
[NCBI]
|
1.08451e-05
|
|
|
GRA
|
[NCBI]
|
1.08348e-05
|
|
|
MAG
|
[NCBI]
|
1.06981e-05
|
|
|
IL10
|
[NCBI]
|
1.06966e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.06242e-05
|
|
|
ACE
|
[NCBI]
|
1.04621e-05
|
|
|
CCD
|
[NCBI]
|
1.03275e-05
|
|
|
MIA
|
[NCBI]
|
1.01626e-05
|
|
|
HLA-DPB1
|
[NCBI]
|
1.01626e-05
|
|
|
FIP1L1
|
[NCBI]
|
1.01626e-05
|
|
|
CRYBA4
|
[NCBI]
|
1.01626e-05
|
|
|
FABP4
|
[NCBI]
|
1.01626e-05
|
|
|
GIP
|
[NCBI]
|
1.00984e-05
|
|
|
PI
|
[NCBI]
|
1.00563e-05
|
|
|
breast cancer
|
[NCBI]
|
9.95175e-06
|
|
|
STAT3
|
[NCBI]
|
9.75135e-06
|
|
|
hydrocephalus
|
[NCBI]
|
9.7355e-06
|
|
|
ICAM1
|
[NCBI]
|
9.70554e-06
|
|
|
TS
|
[NCBI]
|
9.66802e-06
|
|
|
SCA2
|
[NCBI]
|
9.57986e-06
|
|
|
PTGFR
|
[NCBI]
|
9.37541e-06
|
|
|
CTGF
|
[NCBI]
|
9.23571e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
9.21191e-06
|
|
|
PSCA
|
[NCBI]
|
9.19322e-06
|
|
|
LTA
|
[NCBI]
|
9.19322e-06
|
|
|
HRG
|
[NCBI]
|
9.01559e-06
|
|
|
LSA
|
[NCBI]
|
9.01531e-06
|
|
|
homocysteinemia
|
[NCBI]
|
9.01531e-06
|
|
|
graves disease
|
[NCBI]
|
9.01531e-06
|
|
|
SLPI
|
[NCBI]
|
8.69637e-06
|
|
|
FGF20
|
[NCBI]
|
8.69539e-06
|
|
|
SOD3
|
[NCBI]
|
8.69539e-06
|
|
|
HTR2C
|
[NCBI]
|
8.69539e-06
|
|
|
MPO
|
[NCBI]
|
8.64568e-06
|
|
|
SLC6A3
|
[NCBI]
|
8.59225e-06
|
|
|
LCAT
|
[NCBI]
|
8.43421e-06
|
|
|
WSS
|
[NCBI]
|
8.37826e-06
|
|
|
cirrhosis, familial
|
[NCBI]
|
8.37826e-06
|
|
|
FGF7
|
[NCBI]
|
8.15119e-06
|
|
|
ALS1
|
[NCBI]
|
8.13276e-06
|
|
|
CAT
|
[NCBI]
|
8.08589e-06
|
|
|
HLA-DRA
|
[NCBI]
|
8.04997e-06
|
|
|
SST
|
[NCBI]
|
7.93783e-06
|
|
|
LPA
|
[NCBI]
|
7.84196e-06
|
|
|
HK2
|
[NCBI]
|
7.56824e-06
|
|
|
CMT1A
|
[NCBI]
|
7.43516e-06
|
|
|
ACP5
|
[NCBI]
|
7.32853e-06
|
|
|
AOS
|
[NCBI]
|
7.31649e-06
|
|
|
sarcoidosis
|
[NCBI]
|
7.20401e-06
|
|
|
BCHE
|
[NCBI]
|
7.20186e-06
|
|
|
loc387715 gene
|
[NCBI]
|
7.09224e-06
|
|
|
ITPA
|
[NCBI]
|
7.09224e-06
|
|
|
KIR2DL1
|
[NCBI]
|
7.09224e-06
|
|
|
APCS
|
[NCBI]
|
7.0688e-06
|
|
|
PZP
|
[NCBI]
|
7.0688e-06
|
|
|
TCF7L2
|
[NCBI]
|
7.0688e-06
|
|
|
JMML
|
[NCBI]
|
6.90458e-06
|
|
|
LQT1
|
[NCBI]
|
6.67196e-06
|
|
|
CRYGC
|
[NCBI]
|
6.66148e-06
|
|
|
ABCC1
|
[NCBI]
|
6.47432e-06
|
|
|
CMD1A
|
[NCBI]
|
6.43405e-06
|
|
|
IL6
|
[NCBI]
|
6.34884e-06
|
|
|
MUC1
|
[NCBI]
|
6.31104e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
6.30909e-06
|
|
|
CDX2
|
[NCBI]
|
6.26898e-06
|
|
|
GDF15
|
[NCBI]
|
6.26898e-06
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
6.18212e-06
|
|
|
autoimmune disease
|
[NCBI]
|
6.18212e-06
|
|
|
XFS
|
[NCBI]
|
6.18212e-06
|
|
|
SVAS
|
[NCBI]
|
6.09733e-06
|
|
|
B2M
|
[NCBI]
|
6.06066e-06
|
|
|
MAP2
|
[NCBI]
|
6.05597e-06
|
|
|
CRYGD
|
[NCBI]
|
5.90926e-06
|
|
|
HIC1
|
[NCBI]
|
5.90926e-06
|
|
|
TNNI3
|
[NCBI]
|
5.90926e-06
|
|
|
FSHB
|
[NCBI]
|
5.90926e-06
|
|
|
HABP2
|
[NCBI]
|
5.90926e-06
|
|
|
CADASIL
|
[NCBI]
|
5.88703e-06
|
|
|
ABP1
|
[NCBI]
|
5.62052e-06
|
|
|
A2M
|
[NCBI]
|
5.61402e-06
|
|
|
SOD1
|
[NCBI]
|
5.60985e-06
|
|
|
TBX21
|
[NCBI]
|
5.57794e-06
|
|
|
ALOX5AP
|
[NCBI]
|
5.57794e-06
|
|
|
SCZD
|
[NCBI]
|
5.54311e-06
|
|
|
ACH
|
[NCBI]
|
5.5303e-06
|
|
|
ADM
|
[NCBI]
|
5.52154e-06
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
5.5032e-06
|
|
|
prostate cancer
|
[NCBI]
|
5.45962e-06
|
|
|
malaria, susceptibility to
|
[NCBI]
|
5.37471e-06
|
|
|
VHL
|
[NCBI]
|
5.29571e-06
|
|
|
LGMD2I
|
[NCBI]
|
5.28908e-06
|
|
|
tetralogy of fallot
|
[NCBI]
|
5.28908e-06
|
|
|
ARMD4
|
[NCBI]
|
5.28908e-06
|
|
|
ADRB1
|
[NCBI]
|
5.27146e-06
|
|
|
IGF1
|
[NCBI]
|
5.06929e-06
|
|
|
ALPS
|
[NCBI]
|
5.05241e-06
|
|
|
SCNN1B
|
[NCBI]
|
4.9869e-06
|
|
|
GNB3
|
[NCBI]
|
4.9869e-06
|
|
|
AMFR
|
[NCBI]
|
4.9869e-06
|
|
|
KRAS
|
[NCBI]
|
4.94138e-06
|
|
|
porphyria variegata
|
[NCBI]
|
4.7335e-06
|
|
|
CYP1A1
|
[NCBI]
|
4.73206e-06
|
|
|
BHMT
|
[NCBI]
|
4.72181e-06
|
|
|
PAPPA
|
[NCBI]
|
4.72181e-06
|
|
|
IL6R
|
[NCBI]
|
4.72181e-06
|
|
|
APOB
|
[NCBI]
|
4.50437e-06
|
|
|
AKR1B1
|
[NCBI]
|
4.48774e-06
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
4.47414e-06
|
|
|
GUCY2D
|
[NCBI]
|
4.47414e-06
|
|
|
SLC6A8
|
[NCBI]
|
4.47414e-06
|
|
|
HFM
|
[NCBI]
|
4.44778e-06
|
|
|
aHUS
|
[NCBI]
|
4.44657e-06
|
|
|
CCL17
|
[NCBI]
|
4.2357e-06
|
|
|
CP
|
[NCBI]
|
4.20365e-06
|
|
|
SSTR2
|
[NCBI]
|
4.02433e-06
|
|
|
CCL2
|
[NCBI]
|
4.02194e-06
|
|
|
SLS
|
[NCBI]
|
3.96814e-06
|
|
|
SERPINA6
|
[NCBI]
|
3.88077e-06
|
|
|
BRCA1
|
[NCBI]
|
3.86865e-06
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
3.81943e-06
|
|
|
GCE
|
[NCBI]
|
3.81943e-06
|
|
|
TTP
|
[NCBI]
|
3.81943e-06
|
|
|
alexander disease
|
[NCBI]
|
3.81943e-06
|
|
|
AMPD1
|
[NCBI]
|
3.81942e-06
|
|
|
GATA4
|
[NCBI]
|
3.81942e-06
|
|
|
DLK1
|
[NCBI]
|
3.81942e-06
|
|
|
FGFR3
|
[NCBI]
|
3.73554e-06
|
|
|
POAG
|
[NCBI]
|
3.6358e-06
|
|
|
LKS
|
[NCBI]
|
3.6358e-06
|
|
|
LAMB3
|
[NCBI]
|
3.62627e-06
|
|
|
RHD
|
[NCBI]
|
3.62627e-06
|
|
|
TLR2
|
[NCBI]
|
3.58778e-06
|
|
|
PRL
|
[NCBI]
|
3.58526e-06
|
|
|
XDH
|
[NCBI]
|
3.51807e-06
|
|
|
BIRC5
|
[NCBI]
|
3.44391e-06
|
|
|
G6PD
|
[NCBI]
|
3.40494e-06
|
|
|
EGFR
|
[NCBI]
|
3.37487e-06
|
|
|
MG
|
[NCBI]
|
3.36039e-06
|
|
|
MLH1
|
[NCBI]
|
3.34694e-06
|
|
|
FKRP
|
[NCBI]
|
3.27147e-06
|
|
|
HLA-DRB1
|
[NCBI]
|
3.27147e-06
|
|
|
NKX2E
|
[NCBI]
|
3.27147e-06
|
|
|
AQP5
|
[NCBI]
|
3.27147e-06
|
|
|
SLC3A1
|
[NCBI]
|
3.27147e-06
|
|
|
SCCMS
|
[NCBI]
|
3.21608e-06
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
3.21608e-06
|
|
|
CORD2
|
[NCBI]
|
3.21608e-06
|
|
|
ICP
|
[NCBI]
|
3.21608e-06
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
3.21608e-06
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
3.21608e-06
|
|
|
ALK
|
[NCBI]
|
3.183e-06
|
|
|
HTR2A
|
[NCBI]
|
3.1082e-06
|
|
|
fabry disease
|
[NCBI]
|
3.06188e-06
|
|
|
NPPA
|
[NCBI]
|
3.04665e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
2.97175e-06
|
|
|
CTSK
|
[NCBI]
|
2.9534e-06
|
|
|
OPA1
|
[NCBI]
|
2.9534e-06
|
|
|
SFRP1
|
[NCBI]
|
2.9534e-06
|
|
|
MTR
|
[NCBI]
|
2.92627e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
2.81469e-06
|
|
|
GAS
|
[NCBI]
|
2.80648e-06
|
|
|
TNNT2
|
[NCBI]
|
2.80648e-06
|
|
|
PROP1
|
[NCBI]
|
2.80648e-06
|
|
|
GPX1
|
[NCBI]
|
2.80648e-06
|
|
|
TPO
|
[NCBI]
|
2.70129e-06
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
2.68654e-06
|
|
|
FTLDU
|
[NCBI]
|
2.68654e-06
|
|
|
SHEP2
|
[NCBI]
|
2.68654e-06
|
|
|
factor xii deficiency
|
[NCBI]
|
2.68654e-06
|
|
|
MB
|
[NCBI]
|
2.6604e-06
|
|
|
HHF2
|
[NCBI]
|
2.64625e-06
|
|
|
CCM
|
[NCBI]
|
2.64625e-06
|
|
|
AN2
|
[NCBI]
|
2.64625e-06
|
|
|
MHS1
|
[NCBI]
|
2.64625e-06
|
|
|
NOS2A
|
[NCBI]
|
2.53415e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
2.48584e-06
|
|
|
PEDF
|
[NCBI]
|
2.41581e-06
|
|
|
IRS2
|
[NCBI]
|
2.40781e-06
|
|
|
complement component 6 deficiency
|
[NCBI]
|
2.40781e-06
|
|
|
MSH6
|
[NCBI]
|
2.40781e-06
|
|
|
HNPP
|
[NCBI]
|
2.40521e-06
|
|
|
NF2
|
[NCBI]
|
2.40521e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
2.40521e-06
|
|
|
VASP
|
[NCBI]
|
2.38662e-06
|
|
|
LAM
|
[NCBI]
|
2.30224e-06
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
2.28746e-06
|
|
|
GCH1
|
[NCBI]
|
2.28746e-06
|
|
|
CETP
|
[NCBI]
|
2.28746e-06
|
|
|
HRPT1
|
[NCBI]
|
2.22259e-06
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
2.22259e-06
|
|
|
pancreatic carcinoma
|
[NCBI]
|
2.22259e-06
|
|
|
ENPP1
|
[NCBI]
|
2.17276e-06
|
|
|
IL8
|
[NCBI]
|
2.17276e-06
|
|
|
MAOB
|
[NCBI]
|
2.17276e-06
|
|
|
FASN
|
[NCBI]
|
2.17276e-06
|
|
|
galactosemia
|
[NCBI]
|
2.1727e-06
|
|
|
MAS
|
[NCBI]
|
2.12876e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
2.03308e-06
|
|
|
SDS
|
[NCBI]
|
2.03308e-06
|
|
|
homocystinuria
|
[NCBI]
|
1.96894e-06
|
|
|
PPARA
|
[NCBI]
|
1.95412e-06
|
|
|
ACADM
|
[NCBI]
|
1.92312e-06
|
|
|
DAP
|
[NCBI]
|
1.85928e-06
|
|
|
GHRL
|
[NCBI]
|
1.85928e-06
|
|
|
EPHX1
|
[NCBI]
|
1.85928e-06
|
|
|
IL13
|
[NCBI]
|
1.85928e-06
|
|
|
LEPR
|
[NCBI]
|
1.79958e-06
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
1.79832e-06
|
|
|
APP
|
[NCBI]
|
1.76708e-06
|
|
|
PAI1
|
[NCBI]
|
1.76407e-06
|
|
|
SCA6
|
[NCBI]
|
1.73473e-06
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
1.6731e-06
|
|
|
HDGF
|
[NCBI]
|
1.58614e-06
|
|
|
PTPRC
|
[NCBI]
|
1.58614e-06
|
|
|
OPTN
|
[NCBI]
|
1.58614e-06
|
|
|
SCIDX1
|
[NCBI]
|
1.53008e-06
|
|
|
GAMT
|
[NCBI]
|
1.503e-06
|
|
|
pfeiffer syndrome
|
[NCBI]
|
1.46484e-06
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
1.46484e-06
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
1.46484e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
1.42348e-06
|
|
|
GRN
|
[NCBI]
|
1.42348e-06
|
|
|
FGFR2
|
[NCBI]
|
1.36099e-06
|
|
|
CSF2
|
[NCBI]
|
1.34743e-06
|
|
|
TP53
|
[NCBI]
|
1.32972e-06
|
|
|
MMP3
|
[NCBI]
|
1.27466e-06
|
|
|
CASR
|
[NCBI]
|
1.2431e-06
|
|
|
F3
|
[NCBI]
|
1.22684e-06
|
|
|
LPL
|
[NCBI]
|
1.22328e-06
|
|
|
BRAF
|
[NCBI]
|
1.20505e-06
|
|
|
GHR
|
[NCBI]
|
1.19265e-06
|
|
|
AVP
|
[NCBI]
|
1.16582e-06
|
|
|
obesity
|
[NCBI]
|
1.16081e-06
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
1.16013e-06
|
|
|
PPH1
|
[NCBI]
|
1.16013e-06
|
|
|
mucolipidosis iv
|
[NCBI]
|
1.16013e-06
|
|
|
JPS
|
[NCBI]
|
1.15164e-06
|
|
|
XPA
|
[NCBI]
|
1.15164e-06
|
|
|
ENG
|
[NCBI]
|
1.13844e-06
|
|
|
NF1
|
[NCBI]
|
1.08275e-06
|
|
|
DAZ
|
[NCBI]
|
1.0747e-06
|
|
|
PTEN
|
[NCBI]
|
1.07308e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
1.01372e-06
|
|
|
HSAN3
|
[NCBI]
|
9.78819e-07
|
|
|
TSC1
|
[NCBI]
|
9.55374e-07
|
|
|
NS1
|
[NCBI]
|
9.397e-07
|
|
|
PPARG
|
[NCBI]
|
9.22132e-07
|
|
|
CHNG2
|
[NCBI]
|
8.98842e-07
|
|
|
PRF1
|
[NCBI]
|
8.46174e-07
|
|
|
COL3A1
|
[NCBI]
|
8.46174e-07
|
|
|
SCA7
|
[NCBI]
|
8.24195e-07
|
|
|
BMD
|
[NCBI]
|
8.1765e-07
|
|
|
RP2
|
[NCBI]
|
7.95122e-07
|
|
|
TPMT
|
[NCBI]
|
7.91159e-07
|
|
|
SPINK1
|
[NCBI]
|
7.01239e-07
|
|
|
CFB
|
[NCBI]
|
6.99666e-07
|
|
|
HGF
|
[NCBI]
|
6.82621e-07
|
|
|
SCDO1
|
[NCBI]
|
6.77198e-07
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
6.77198e-07
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
6.6871e-07
|
|
|
PYY
|
[NCBI]
|
6.59905e-07
|
|
|
PPR
|
[NCBI]
|
6.56815e-07
|
|
|
AGT
|
[NCBI]
|
6.55097e-07
|
|
|
ABL1
|
[NCBI]
|
6.12532e-07
|
|
|
IGFALS
|
[NCBI]
|
5.91792e-07
|
|
|
BRCA2
|
[NCBI]
|
5.73819e-07
|
|
|
MSH2
|
[NCBI]
|
5.719e-07
|
|
|
MYH7
|
[NCBI]
|
5.719e-07
|
|
|
KIT
|
[NCBI]
|
5.719e-07
|
|
|
HHF1
|
[NCBI]
|
5.32626e-07
|
|
|
RET
|
[NCBI]
|
5.30367e-07
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
5.06717e-07
|
|
|
DCC
|
[NCBI]
|
4.96163e-07
|
|
|
NAT1
|
[NCBI]
|
4.96163e-07
|
|
|
DRD2
|
[NCBI]
|
4.96163e-07
|
|
|
SPS
|
[NCBI]
|
4.63504e-07
|
|
|
hurler syndrome
|
[NCBI]
|
4.38149e-07
|
|
|
von willebrand disease
|
[NCBI]
|
4.27587e-07
|
|
|
CDKN2A
|
[NCBI]
|
4.27587e-07
|
|
|
INS
|
[NCBI]
|
4.10222e-07
|
|
|
HD
|
[NCBI]
|
4.03832e-07
|
|
|
CCND1
|
[NCBI]
|
3.88923e-07
|
|
|
MAPT
|
[NCBI]
|
3.70138e-07
|
|
|
NOS3
|
[NCBI]
|
3.65115e-07
|
|
|
DGS
|
[NCBI]
|
3.64393e-07
|
|
|
phenylketonuria
|
[NCBI]
|
3.51248e-07
|
|
|
lung cancer
|
[NCBI]
|
3.40012e-07
|
|
|
osteoarthritis
|
[NCBI]
|
3.40012e-07
|
|
|
JAK2
|
[NCBI]
|
3.37367e-07
|
|
|
ITGB3
|
[NCBI]
|
3.3629e-07
|
|
|
PKD1
|
[NCBI]
|
3.16038e-07
|
|
|
UCP2
|
[NCBI]
|
3.16038e-07
|
|
|
LCN2
|
[NCBI]
|
3.08941e-07
|
|
|
CYP19A1
|
[NCBI]
|
3.08941e-07
|
|
|
lactase persistence
|
[NCBI]
|
3.01786e-07
|
|
|
LFS1
|
[NCBI]
|
3.01786e-07
|
|
|
COH1
|
[NCBI]
|
3.01786e-07
|
|
|
OCA1A
|
[NCBI]
|
3.01786e-07
|
|
|
NPM1
|
[NCBI]
|
2.98778e-07
|
|
|
UGT1A1
|
[NCBI]
|
2.83023e-07
|
|
|
TLR9
|
[NCBI]
|
2.65453e-07
|
|
|
RNASE2
|
[NCBI]
|
2.49402e-07
|
|
|
NMU
|
[NCBI]
|
2.35307e-07
|
|
|
DFNB1
|
[NCBI]
|
2.18988e-07
|
|
|
AGER
|
[NCBI]
|
2.1522e-07
|
|
|
PLG
|
[NCBI]
|
2.08787e-07
|
|
|
SMA3
|
[NCBI]
|
2.08554e-07
|
|
|
OPA1
|
[NCBI]
|
2.08554e-07
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
2.08554e-07
|
|
|
kartagener syndrome
|
[NCBI]
|
2.08554e-07
|
|
|
PLAUR
|
[NCBI]
|
2.0378e-07
|
|
|
PTHLH
|
[NCBI]
|
1.98229e-07
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.92818e-07
|
|
|
HMBS
|
[NCBI]
|
1.87791e-07
|
|
|
MAOA
|
[NCBI]
|
1.75546e-07
|
|
|
TFF3
|
[NCBI]
|
1.73439e-07
|
|
|
PCI
|
[NCBI]
|
1.62107e-07
|
|
|
TTR
|
[NCBI]
|
1.55224e-07
|
|
|
PHS
|
[NCBI]
|
1.26534e-07
|
|
|
HSAS
|
[NCBI]
|
1.26534e-07
|
|
|
TSC2
|
[NCBI]
|
1.22357e-07
|
|
|
MC4R
|
[NCBI]
|
1.22357e-07
|
|
|
LOX
|
[NCBI]
|
1.07574e-07
|
|
|
FSHR
|
[NCBI]
|
1.07574e-07
|
|
|
COMT
|
[NCBI]
|
1.06168e-07
|
|
|
MC1R
|
[NCBI]
|
1.02009e-07
|
|
|
MVP
|
[NCBI]
|
9.3864e-08
|
|
|
SLC4A1
|
[NCBI]
|
9.3864e-08
|
|
|
LEP
|
[NCBI]
|
8.94432e-08
|
|
|
GHRH
|
[NCBI]
|
8.42284e-08
|
|
|
GIST
|
[NCBI]
|
8.38011e-08
|
|
|
SPG4
|
[NCBI]
|
7.07742e-08
|
|
|
PARK2
|
[NCBI]
|
6.95485e-08
|
|
|
FTD
|
[NCBI]
|
6.9176e-08
|
|
|
APOA1
|
[NCBI]
|
5.88902e-08
|
|
|
RYR1
|
[NCBI]
|
5.88902e-08
|
|
|
FMF
|
[NCBI]
|
5.85369e-08
|
|
|
LMNA
|
[NCBI]
|
5.45667e-08
|
|
|
UGB
|
[NCBI]
|
4.91977e-08
|
|
|
IL4
|
[NCBI]
|
4.67038e-08
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
4.20807e-08
|
|
|
CCL22
|
[NCBI]
|
4.0447e-08
|
|
|
PCD
|
[NCBI]
|
3.00504e-08
|
|
|
PARK2
|
[NCBI]
|
2.81835e-08
|
|
|
CVS
|
[NCBI]
|
2.81835e-08
|
|
|
CPI
|
[NCBI]
|
2.75602e-08
|
|
|
GJB2
|
[NCBI]
|
1.63672e-08
|
|
|
HP
|
[NCBI]
|
1.63561e-08
|
|
|
HFE
|
[NCBI]
|
1.32047e-08
|
|
|
ABCC2
|
[NCBI]
|
1.18294e-08
|
|
|
GCK
|
[NCBI]
|
8.18039e-09
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
4.58322e-09
|
|
|
cystinuria
|
[NCBI]
|
4.58322e-09
|
|
|
ZFP36
|
[NCBI]
|
3.70892e-09
|
|
|
CHH
|
[NCBI]
|
2.39806e-09
|
|
|
TNFRSF1A
|
[NCBI]
|
1.20528e-09
|
|
|
MEN2A
|
[NCBI]
|
5.65726e-10
|
|
|
TLR4
|
[NCBI]
|
2.6658e-14
|
|